Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | IBB | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 39.54 | 270.31 | 163.71 | ||
| High | 41.23 | 272.09 | 166.75 | ||
| Low | 39.54 | 269.79 | 163.25 | ||
| Latest | 41.13 | 271.77 | 166.18 | ||
| Change | +1.74 | +3.52 | +4.54 | ||
| % Change | +4.41% | +1.31% | +2.81% | ||
| Volume | 5,554 | 93,847 | 829,426 | ||
| 20-Day Average Volume | 16,873 | 208,696 | 1,711,039 | ||
| Previous Close | 39.39 | 268.25 | 161.64 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.39 | 280.52 | 168.18 | ||
| 20-Day Raw Stochastic | 44.51% | 20.03% | 42.03% | ||
| 20-Day Relative Strength | 50.84 | 37.00 | 46.26 | ||
| Weighted Alpha | +121.78 | +3.21 | +27.36 | ||
| Today's Opinion | 56% Buy | 8% Sell | 8% Buy | ||
| Previous Opinion | 56% Buy | 24% Sell | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.11% since 03/18/26 | -0.31% since 03/18/26 | +1.60% since 03/18/26 | ||
| Low | 38.84 on 03/24/26 | 265.73 on 03/24/26 | 159.68 on 03/24/26 | ||
| High | 41.23 on 03/25/26 | 273.99 on 03/19/26 | 166.75 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -3.79% since 02/25/26 | -6.91% since 02/25/26 | -5.08% since 02/25/26 | ||
| Low | 38.84 on 03/24/26 | 265.73 on 03/24/26 | 159.68 on 03/24/26 | ||
| High | 43.99 on 03/10/26 | 295.64 on 02/27/26 | 175.67 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +2.01% since 12/24/25 | -6.45% since 12/24/25 | -3.95% since 12/24/25 | ||
| Low | 36.22 on 01/05/26 | 265.73 on 03/24/26 | 159.68 on 03/24/26 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +60.35% since 09/25/25 | +8.56% since 09/25/25 | +19.65% since 09/25/25 | ||
| Low | 25.87 on 09/26/25 | 251.24 on 09/26/25 | 139.20 on 09/26/25 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,453 | 16,140,603 | 8,001,180 | ||
| Shares Outstanding, K | 900 | 60,170 | 49,500 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.01 | 0.67 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 0.994 on 03/24/26 | 0.122 on 03/17/26 | ||
| Next Ex-Dividends Date | 12/22/25 | 03/24/26 | 03/17/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.40 | 26.01 | ||